First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau, Linda M

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. [electronic resource] - Journal of translational medicine 05 2018 - 142 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1479-5876

10.1186/s12967-018-1507-6 doi


Adult
Aged
Brain Neoplasms--diagnosis
Cancer Vaccines--adverse effects
Dendritic Cells--immunology
Endpoint Determination
Female
Glioblastoma--diagnosis
Humans
Male
Middle Aged
Prognosis
Survival Analysis
Treatment Outcome
Young Adult